Home > Financial Ratios > INDOCO REMEDIES

INDOCO REMEDIES
Working Capital/Sales

    Back to All Ratios
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

INDOCO REMEDIES Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 8.615.314.294.425.76

What is the latest Working Capital/Sales ratio of INDOCO REMEDIES ?

The latest Working Capital/Sales ratio of INDOCO REMEDIES is 8.61 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20258.61
Mar20245.31
Mar20234.29
Mar20224.42
Mar20215.76

How is Working Capital/Sales of INDOCO REMEDIES Trending?

Years Working Capital/Sales % Change
Mar2025 8.61
62.15
Mar2024 5.31
23.78
Mar2023 4.29
-2.94
Mar2022 4.42
-23.26
Mar2021 5.76 -

Other Financial Ratios of INDOCO REMEDIES


Compare Working Capital/Sales ratio of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹1,765.7 Cr 0.9% -5.9% -13.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,470.0 Cr -0.3% 3.1% 2.2% Stock Analytics
DIVIS LABORATORIES ₹161,996.0 Cr 0.5% -2.9% 5.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,440.0 Cr 0.1% 1.4% 37.6% Stock Analytics
DR REDDYS LABORATORIES ₹108,417.0 Cr 1.9% 1.4% 10.7% Stock Analytics
CIPLA ₹101,445.0 Cr -3.3% -6.9% -17% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

0.9%

-5.9%

-13.6%

SENSEX

-0%

-10.7%

1%


You may also like the below Video Courses